Dec 21, 2020
A short statement has been released by BIVDA’s Chief Operating Officer Helen Dent on the COVID-19 border closures. Helen said; “Similarly to pharmaceutical companies, BIVDA members have planned contingencies in place for border emergencies in line with business continuity planning, which includes buffer stock and the ability to re-route supplies. Therefore, the provision of Diagnostic testing supplies will continue. We continue to monitor events and suppliers are working w...
Dec 16, 2020
LEX Diagnostics is developing a point-of-care PCR platform that is a major improvement in speed, cost and ease-of-use over all existing molecular diagnostics in the market today. Originally designed as an influenza & RSV platform specifically for use in primary care, LEX is playing its part in getting us through the current Covid pandemic with a combined flu/Covid test providing an answer in around 5 minutes – even for low viral load samples. The entire process from swab elution throug...
Dec 02, 2020
BIVDA Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 vaccine to be approved by British regulators. Doris-Ann said; “We are delighted that the MHRA have approved the Pfizer/BioNTech coronavirus vaccine for widespread use, meaning it can start its roll out from next week. On behalf of BIVDA and the in vitro diagnostics sector, I would like to congratulate all those involved in this incredible scientific achievement. An effective v...
Nov 30, 2020
BIVDA Chief Executive Doris-Ann Williams has commented on the launch of the Medicines and Diagnostic Manufacturing Transformation Fund. “We welcome the announcement of the Medicines and Diagnostic Manufacturing Transformation Fund by the Prime Minister today. The lessons the country has learned during this difficult year in pandemic response must not be forgotten, and the innovations should be used to improve our diagnostic testing system for non-COVID illnesses including cancer...
Nov 25, 2020
BIVDA Comments on Spending Review 2020 BIVDA has commented on Chancellor Rishi Sunak’s speech to the House of Commons, where he announced the results of the 2020 Spending Review. Outlining measures designed to help the NHS maintain services as it recovers from the ongoing pandemic, the Chancellor announced £3 billion for recovery projects, including enhanced diagnostic testing, and greater capital spending to help replace outdated diagnostics equipment in hospitals. The NHS budg...
Oct 28, 2020
Please see attached a press release from Paragon Health regarding UK-manufactured PPE supplies.
Oct 16, 2020
BIVDA has commented on the Prime Minister’s statement today declaring that the United Kingdom must prepare for a ‘No Deal’ scenario as talks on an agreement stall. Chief Executive Doris-Ann Williams said; “It is concerning to hear the Prime Minister talking of no deal. The smooth import and export of IVD devices is critical to patient care and any potential impact of delays at our ports and airports would impact the most vulnerable. There is sti...
Oct 05, 2020
BIVDA Comments on Chancellor’s Speech to Conservative Party Conference BIVDA Chief Executive Doris-Ann Williams has commented on Chancellor Rishi Sunak’s speech to the Conservative Party Conference. “While the Chancellor’s speech was light on policy, we recognise that the Government has committed to doing what is necessary to support the economy and health service during what will be a difficult winter. A thriving British IVD industry will be crucial for both tr...
Oct 02, 2020
BIVDA welcomes publication of NHS England diagnostics report. BIVDA has warmly welcomed the publication of ‘Diagnostics: Recovery and Renewal’, a major review of diagnostic services by NHS England. One of the main takeaways from the review is the recommendation for the creation of Community Diagnostic Hubs (CHDs) across the country, away from hospitals, which would act as ‘one stop shops’ so that patients can receive life-saving checks...